share_log

Sorrento Therapeutics | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions

Sorrento Therapeutics | 425:募資說明/企業合併公告

2022/03/18 09:03
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息